Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer